With the present study, we show an antibody response against the citrullinated Pg PAD enzyme in a subset of early RA, and presence of citrulline-reactive gingival B cells, which display cross-reactivity between Pg and human peptide antigens, supporting the concept of a bacterial/periodontal origin for the ACPA response. The gene discussed is PRTN3; the disease is rheumatoid arthritis.